Clinical Trial Details


Research Study Summary

When your type 2 diabetes is out of control, finding harmony is essential


If you're having trouble controlling your diabetes, consider participating in HARMONY, a research study evaluating an investigational diabetes medication that's taken only once a week.

Controlling your blood sugar levels can often become a challenge, even with medication, diet, and exercise. Additionally, the inconvenience of multiple daily doses required by other medications can disrupt your daily routine. Now, the HARMONY program is evaluating the effectiveness of an investigational type 2 diabetes medication, which could require less frequent dosings than currently available treatments.

To be eligible for this study, you must be:

  • 18 years of age or older
  • Diagnosed with type 2 diabetes AND
  • Having trouble controlling your blood sugar levels

Can you tell me more about the study drug?
The investigational drug being evaluated in the HARMONY program is called albiglutide. This novel medication comes from a new class of drugs, which are similar to some types of currently approved diabetes drugs. However, albiglutide is designed to have a much longer-lasting effect.

Whereas some current diabetes medications must be administered multiple times a day by injection, researches are expecting that one weekly injection of albiglutide will prove to be effective in helping control type2 diabetes.

All study participants receiving treatment with albiglutide will be given an injector pen. The study staff will instruct you on how to use this pen at home to administer your injections.

Why conduct medical research studies?
Medications must be carefully tested through medical research studies to demonstarte their safety and effectiveness before pharmaceutical companies are allowed to sell them to the public. Companies can then apply to regulatory agencies for approval to market these drugs to the public.

The researchers conducting this study are required to follow a detailed plan called a protocol, which explains all study procedures. This protocol is approved by an independent board and is designed to protect the safety of all study volunteers. Additionally, researchers must provide potential participants with complete answers to any questions they have about the study.

Medical research studies are necessary to test and, ultimately, develop new treatments for a wide variety of medical conditions. Your participation in the HARMONY program may help researchers find a way to better control type2 diabetes. However, your participation is completely voluntary, and you may leave the study at any time, for any reason.

To learn more about the HARMONY program, please contact:

To Learn more

CW ID: 156060
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Facility Type


Diablo Clinical Research
2255 Ygnacio Valley Rd., Suite M
Walnut Creek, CA 94598
Phone: 925-930-7267
Fax: 925-930-7392

View Map

Research Center Information:

Diablo Clinical Research

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.